Xinlong Health Co., Ltd.

Legal Opinion for 2025 Annual Shareholders' Meeting

Announcement of 2025 Annual Shareholders' Meeting Resolutions

Pre-Disclosure Announcement on the Reduction of Shares by Controlling Shareholders

Prompt Announcement for Public Collection of Questions for the Online Explanation Meeting of the 2025 Annual Report

Notice of the 2025 Annual Shareholders' Meeting

Announcement of Resolutions from the Fourth Meeting of the Eighth Board of Directors

2026 First Quarter Report

Shareholder Return Plan for the Next Three Years (2026-2028)

2025 Independent Director Work Report - Gao Haijun (Term Expired)

2025 Independent Director Work Report - Hua Xiaoning

2025 Independent Director Work Report - Gan Yongming

2025 Independent Director Work Report - Zhao Feng

2025 Independent Director Work Report - Luo Rui

2025 Independent Director Work Report - Wang Wei (Term Expired)

Announcement on the Online Performance Briefing for the 2025 Annual Report

Internal Control Audit Report of Shenzhen Xinlong Health Industry Development Co., Ltd. No. [2026] 7478

2025 Internal Control Evaluation Report

Announcement on the Provision for Asset Impairment

Announcement on Expected Daily Related Transactions for 2026

Resolution Announcement of the Third Meeting of the Eighth Board of Directors

Announcement on the Profit Distribution Plan for 2025

Special Audit Explanation on the Deduction of Operating Income for 2025 of Shenzhen Xinlong Health Industry Development Co., Ltd. No. [2026] 7480

Evaluation Report on the Performance of the Accounting Firm in 2025

Report of the Audit Committee on the Supervision Responsibilities of the Accounting Firm in 2025

Special Audit Explanation on Non-operating Fund Occupation and Other Related Fund Transactions of Shenzhen Xinlong Health Industry Development Co., Ltd. No. [2026] 7479

Summary Table of Non-operating Fund Occupation and Other Related Fund Transactions for 2025

Special Report of the Board of Directors on the Self-examination of the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement on the expiration of the implementation period of the controlling shareholder's reduction plan

Director and Senior Management Remuneration System (March 2026)

Announcement on Continuing to Conduct Forward Foreign Exchange Transactions in 2026

Announcement on Providing Guarantees to Tianjin Xinlong in 2026

Announcement of Resolutions of the Second Meeting of the Eighth Board of Directors